Cumulus Neuroscience

We’re proud to announce the successful recertification of our ISO 13485 Quality Management System, with zero non-compliances and a commendation for our eQMS! Thank you to our entire team for their hard work and dedication in maintaining such high standards

Cumulus is excited to be a Health Tech Challengers 2024 finalist in the AI Supported Healthcare category! Join us in Barcelona 4-5 Dec for a pitch battle focused on disruptive products that will transform the future of health! #AI #HealthTech #HTC2024

Cumulus is excited to share data from our first-in-class study which were presented at the 2024 #Alzheimers Association International Conference (#AAIC24) on July 27 & 30. Click to learn more: tinyurl.com/2td4r65p #AAIC2024 #endalz #digitalbiomarkers

Cumulus is pleased to announce the presentation of two posters at the 2024 #Alzheimers Association International Conference (#AAIC24) on July 27 & 30 in Philadelphia. #AAIC2024 #endalz #digitalbiomarkers Learn more: tinyurl.com/4edjxefs

Join Cumulus Co-founder and CSO, Brian Murphy, PhD at the 7th Annual Digital Biomarkers in Clinical Trials Summit hosted by Roche. Brian will be a panelist in the session “Digital Biomarkers in Neuroscience Today”. #digitalbiomarkers #CNS #clinicaltrials

Its World #Schizophrenia Awareness Day 2024. 1/3 of all cases go undiagnosed. We need better tools that provide objective measures to identify patients and help discover next gen treatments #EEG #neuroscience #digitalbiomarkers tinyurl.com/29twt66a

For #AlzheimersAwarenessMonth, @CumulusNeuro is honored to be sponsoring a webinar on Friday November 10th titled "Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies". #ENDALZ #CNS #neuroscience

Our research collaborator at the #TrinityCollegeDublin is excited to share interim data from our CNS-102 study at the @PsychSocIreland (PSI) Annual Meeting in Cork on Nov 8th from 2-3pm GMT @tcddublin #CNS #ALS #trinitycollege #PrecisionALS #PSIConf23

Subtle changes in cognition are hard to measure in dementia clinical trials. Data presented at #CTAD2023 confirm it is feasible for #Alzheimers patients to use the Cumulus Platform to provide objective, frequent measures of cognitive function in the home.

Cumulus is proud to share that our Co-founder & CSO Brian Murphy was a featured on a panel titled “Engaging Consumers in Brain Health” moderated by Nicolas Pokorny of #Abbvie at #LausanneX on Oct 12th alongside Matt Trevithick of Blank Slate Technologies.

We are delighted to be showcased as one of the 50 companies in @PwC_UK's Life Sciences Future50 report, illustrating the world-class science and innovation being led by the UK. Find out more here: bit.ly/45Eo8NF #LifeSciences #BioTech #DigitalHealth

We are delighted to be showcased as one of the 50 companies in @PwC_UK's Life Sciences Future50 report, illustrating the world-class science and innovation being led by the UK. Find out more: bit.ly/45Eo8NF #LifeSciences #BioTech #DigitalHealth"

Cumulus is pleased to announce acceptance of 3 posters by the #CTAD23 Scientific Committee. Our team is excited to sharing these data with you in Boston 10/25-27. #Alzheimers #endalz #ADresearch #decentralizedclinicaltrials #clinicaltrials #digitalhealth

At #ECNP2023 in Barcelona on Oct 10th, Cumulus shared exciting new data which demonstrated that translational markers of LTP can be collected at home with minimal support using our FDA-cleared dry sensor 16-channel EEG headset. tinyurl.com/4ya99wx9

Cumulus Neuroscience is excited to announce that CSO and Co-Founder Brian Murphy, PhD is a featured panelist at the upcoming Lausanne X Workshop on October 12th. #LausanneX #Alzheimers #EndAlzheimers #CNS tinyurl.com/mv5t9dd2

It is estimated that at least 1 in 20 children aged 18 and under worldwide are living with #ADHD. We are honored to work alongside our collaborators at @tcddublin and ADMiRE, the HSE’s first specialist service for children and adolescents with ADHD.

Announcing acceptance of our poster “A low-burden visual evoked potential measurement of neuroplasticity: real-world feasibility and data quality from an at-home pilot study”. Excited to share data at #ECNP2023 Oct 10! #CNS tinyurl.com/4ws8cve8

Cumulus Neuroscience is proud to announce that our CCO Tina Sampath will be a panelist at the upcoming @HBAnet event Digital Health- Empowering the Future of Healthcare hosted by @Genentech on September 27 from 5 – 8 PM PT.

Cumulus is excited to announce we've been selected to showcase our Neuroassessment Platform at the Northern Ireland Investment Summit. On Sept 13th, join Ali Buick, Head of Global Business Development and Siggi Saevarsson, COO at the ICC, Belfast #NIIS23

September is World #Alzheimers Month. We're honored to work with @INmuneBio on a Ph1 POC study of XPro1595, a protein biologic with a novel MOA targeting pathological inflammation using #digitalbiomarkers in a real-world setting, both in-clinic and at home